Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Federal court blocks Trump DOJ from obtaining transgender youth medical records in California

A federal judge halted the Trump administration's effort to obtain medical records and names of young patients treated at transgender clinics in California. The Department of Justice had sought the files and information about healthcare providers.

06/16/2026 · Massachusetts edition

Advertisement

Advertisement

A federal judge in California blocked the Trump administration's attempt to access medical records and identifying information about youth who received care at transgender clinics, at least for now.

The Department of Justice had sought patient files containing names of young people treated at gender-affirming clinics, along with information identifying hospital staff who provided the care. A judge granted a temporary restraining order halting the request, preventing federal authorities from obtaining the records during ongoing litigation.

The ruling came after medical providers and patients challenged the government's demand. Legal advocates said the order protects patient privacy while the case proceeds through the courts.

Details about which specific clinics the DOJ targeted and the scope of the original records request were not immediately clear. The temporary restraining order remains in effect pending further court proceedings.

The case reflects broader tension between the Trump administration's stated policy objectives and existing privacy protections governing medical information. Federal law, including the Health Insurance Portability and Accountability Act, restricts how healthcare providers can share patient data with government agencies.

Transgender healthcare has become a focal point of policy disputes. The administration has previously signaled opposition to gender-affirming medical treatments for minors, though enforcement mechanisms and implementation details have varied across federal agencies.

The judge's action prevents the DOJ from enforcing its records request while the legal challenge moves forward. Attorneys for the clinics and patients argued the government overstepped its authority in demanding the materials.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Massachusetts

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Massachusetts

health

Discussion Addresses Mental Health, Suicide Trends in Black Community

NPR's Michel Martin hosted a panel discussion on mental health and suicide within the Black community. The conversation explored the subject through personal perspectives. Participants shared individual experiences.

Read Story →
health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
health

Report Examines Impact of Trump Administration's Drug Pricing Initiatives

A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.

Read Story →
health

Cost of GLP-1 Medications Prompts Search for Alternatives

Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.

Read Story →
health

Experimental Vaccine Shows Promise Against Glioblastoma

An experimental vaccine for glioblastoma, a severe form of brain cancer, demonstrates potential to prolong life for patients. Developers report encouraging results from ongoing studies.

Read Story →
Scroll for more stories